Alpine Immune
AcquiredLeading the Next Evolution of Immunotherapies
Alpine Immune was founded in 2014, is headquartered in Seattle, United States, lists 51–200 employees, and has $108.0M in recorded funding across 3 rounds.
- Headquarters
- Seattle, Washington
- Employees
- 51–200
- Founded
- 2014
- Business Model
- B2B
- Website
- alpineimmunesciences.com
- Total Funding
- $108.0M
- Last Round
- $60.0M Series BJan 2017
- Rounds
- 3
- Acquisition Date
- May 2024
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 5 investors for this company. The full record is or through the API.
About
Clinical-stage biotechnology company developing protein-based immunotherapies for cancer and autoimmune diseases; acquired by Vertex Pharmaceuticals.
Summary
Alpine Immune is a Biotech company based in Seattle, United States, founded in 2014. It lists 51–200 employees. It has raised $108.0M in total across 3 rounds, most recently a $60.0M Series B round in Jan 2017. Investors include Omega Funds, Vertex Pharmaceuticals and OrbiMed.
Funding & Exit History
May 2024
Sign up to see all 6 events
Funding: Seed through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/alpine-immune"><img src="https://indexed.vc/api/badge/company/alpine-immune" alt="Alpine Immune on Indexed.vc" width="260" height="76" /></a>